[1]
Muhammad Roshan, Muhammad Ahmad Nadeem, and Sahar Imran Khalfay, “The paradox of spironolactone: A heart failure treatment with potentially harmful effects”, J Pak Med Assoc, vol. 74, no. 2, pp. 428–428, Jan. 2024.